DEFUSE 3: Late-Stroke Thrombectomy Benefits All Subgroups

Endovascular therapy shouldn’t be withheld because of old age, mild symptoms, or late presentation in large-vessel strokes with salvageable brain tissue, subgroup analysis of the DEFUSE 3 trial suggests.
Medscape Medical News

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s